Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties-Reference-Cited by-同舟云学术

Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties

Published:2010-12 Issue:24 Volume:20 Page:7259-7264
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Tellew John E.,Lanier Marion,Moorjani Manisha,Lin Emily,Luo Zhiyong,Slee Deborah H.,Zhang Xiaohu,Hoare Sam R.J.,Grigoriadis Dimitri E.,Denis Yves St.,Fabio Romano Di,Modugno Enza Di,Saunders John,Williams John P.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. The role of corticotropin-releasing factor in depression and anxiety disorders

2. The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

3. Small Molecule Antagonists of the Corticotropin Releasing Factor (CRF)Receptor: Recent Medicinal Chemistry Developments

4. Chapter 1 Recent Advances in Corticotropin-Releasing Factor Receptor Antagonists

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress-free blood sampling in minipigs: A novel method for assessing 24-h cortisol profiles and drug effects on diurnal and ultradian rhythms;Journal of Pharmacological and Toxicological Methods;2024-05

2. TFA-Mediated Synthesis of 1,2,4-Oxadiazoles from Carbamates and Nitriles;The Journal of Organic Chemistry;2024-04-29

4. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome;Peptides;2022-01

5. Kinetics of Drug-Target Binding: A Guide for Drug Discovery;Reference Module in Biomedical Sciences;2021